Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex.Market will release hair dryers and dumbbells under its new brands

5/24/23 YNDX

Samolet reported for 3 months of 2023 by RAS

5/24/23 SMLT

Sollers plans to assemble up to 10 thousand Argo trucks per year

5/24/23 SVAV

Magnit reported for 3 months of 2023 by RAS

5/24/23 MGNT

Ozon reported for 3 months of 2023

5/24/23 OZON

Rosseti Volga reported for 3 months of 2023 by IFRS

5/24/23 MRKV

Board of Directors of Chelyabinsk Press-Forging Plant recommended that dividends be paid for 2022

5/24/23 CHKZ

Rustore adapts interface for TV and tablets

5/24/23 VKCO

Board of Directors of European Eltech recommended that dividends be paid for 2022

5/24/23 EELT

Xiaomi reported 3 months of 2023

5/24/23 1810